相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Ganjun Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Will CAR T cell therapy have a role in AML? Promises and pitfalls
Katherine D. Cummins et al.
SEMINARS IN HEMATOLOGY (2019)
Antigen Targets for the Development of Immunotherapies in Leukemia
Jens Bauer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred Lo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma
Sairah Ahmed et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
Neema P. Mayor et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Rethinking Thymic Tolerance: Lessons from Mice
Sarah Inglesfield et al.
TRENDS IN IMMUNOLOGY (2019)
Discovery and characterization of actionable tumor antigens
Gregory Ehx et al.
GENOME MEDICINE (2019)
T-cell therapies for T-cell lymphoma
Keri Toner et al.
CYTOTHERAPY (2019)
Updates on CAR T-cell therapy in B-cell malignancies
Elad Jacoby et al.
IMMUNOLOGICAL REVIEWS (2019)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
TGFβ Programs Central Memory Differentiation in Ex Vivo-Stimulated Human T Cells
Amina Dahmani et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Clinical Relevance of Immunobiology in Umbilical Cord Blood Transplantation
Hyun Don Yun et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
Dyantha van der Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials
Natalie Galanina et al.
CANCERS (2019)
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Armin Rashidi et al.
BLOOD ADVANCES (2019)
Update on Aire and thymic negative selection
Geraldo A. Passos et al.
IMMUNOLOGY (2018)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
Maximilian Groeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia
Todd A. Fehniger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients
Katherine A. Baugh et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Jennifer N. Brudno et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Aurelie Durgeau et al.
FRONTIERS IN IMMUNOLOGY (2018)
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia Results From the Microtransplantation Interest Group
Mei Guo et al.
JAMA ONCOLOGY (2018)
Predicting Antigen Presentation - What Could We Learn From a Million Peptides?
David Gfeller et al.
FRONTIERS IN IMMUNOLOGY (2018)
Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation
Elizabeth S. Allen et al.
HUMAN IMMUNOLOGY (2018)
Noncoding regions are the main source of targetable tumor-specific antigens
Celine M. Laumont et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse
Robson G. Dossa et al.
BLOOD (2018)
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut et al.
BLOOD (2018)
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors
Patrizia Comoli et al.
BLOOD (2017)
Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
R. Oostvogels et al.
BONE MARROW TRANSPLANTATION (2017)
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
F. Legrand et al.
BONE MARROW TRANSPLANTATION (2017)
T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
Teresa Manzo et al.
CANCER RESEARCH (2017)
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Maria Parkhurst et al.
CLINICAL CANCER RESEARCH (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Alloimmune T cells in transplantation
Susan DeWolf et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
David Brocks et al.
NATURE GENETICS (2017)
The Antigenicity of the Tumor Cell - Context Matters
Vessela N. Kristensen
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The immunopeptidomic landscape of ovarian carcinomas
Heiko Schuster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immunological effects of hypomethylating agents
Katherine E. Lindblad et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia
Anne M. Dickinson et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul et al.
FRONTIERS IN IMMUNOLOGY (2017)
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS
Isao Tawara et al.
BLOOD (2017)
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
L. E. Franssen et al.
BONE MARROW TRANSPLANTATION (2017)
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
Juliet N. Barker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation
Cor H. J. Lamers et al.
BLOOD (2016)
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
Yusuke Oji et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
MHC class I-associated peptides derive from selective regions of the human genome
Hillary Pearson et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers
D. P. Granados et al.
LEUKEMIA (2016)
Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide
S. R. McCurdy et al.
LEUKEMIA (2016)
Role of non-coding sequence variants in cancer
Ekta Khurana et al.
NATURE REVIEWS GENETICS (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells
Francesca Di Rosa et al.
FRONTIERS IN IMMUNOLOGY (2016)
Autosomal Minor Histocompatibility Antigens: How Genetic variants Create Diversity in immune Targets
Marieke Griffioen et al.
FRONTIERS IN IMMUNOLOGY (2016)
Allorecognition by T Lymphocytes and Allograft Rejection
Jose Marino et al.
FRONTIERS IN IMMUNOLOGY (2016)
Strategies for the Identification of T Cell-Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-versus-Tumor Responses after Allogeneic Blood and Marrow Transplantation
Jenny Zilberberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
The nature of self for T cells - a systems-level perspective
Diana P. Granados et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Early exposure to interleukin-21 limits rapidly generated anti-Epstein-Barr virus T-cell line differentiation
Julie Orio et al.
CYTOTHERAPY (2015)
Stem cell comparison: what can we learn clinically from unrelated cord blood transplantation as an alternative stem cell source?
Filippo Milano et al.
CYTOTHERAPY (2015)
Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
Valerie Janelle et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
Kimberly A. Noonan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Human Tumor Antigens and Cancer Immunotherapy
Nathalie Vigneron
BIOMED RESEARCH INTERNATIONAL (2015)
Neoepitopes of Cancers: Looking Back, Looking Ahead
Pramod K. Srivastava
CANCER IMMUNOLOGY RESEARCH (2015)
A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent
J. J. Scarisbrick et al.
BONE MARROW TRANSPLANTATION (2015)
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
Anniek B. van der Waart et al.
BLOOD (2014)
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment
Elizabeth F. Krakow et al.
BLOOD REVIEWS (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H
Y. Inaguma et al.
GENE THERAPY (2014)
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
Joseph G. Crompton et al.
IMMUNOLOGICAL REVIEWS (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Naive Idiotope-Specific B and T Cells Collaborate Efficiently in the Absence of Dendritic Cells
Johanne Jacobsen et al.
JOURNAL OF IMMUNOLOGY (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides
Diana Paola Granados et al.
NATURE COMMUNICATIONS (2014)
5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
A. O. Gang et al.
BLOOD CANCER JOURNAL (2014)
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
Janice P. Dutcher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute Leukemia
Sanja Stevanovic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
Aude G. Chapuis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs. -myeloma effect
Eleanor M. Tyler et al.
ONCOIMMUNOLOGY (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Edus H. Warren et al.
BLOOD (2012)
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
Pauline Meij et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition
L. J. D'Orsogna et al.
IMMUNOGENETICS (2012)
HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up
Mei Guo et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
T-cell therapy in the treatment of post-transplant lymphoproliferative disease
Catherine M. Bollard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Advances in graft-versus-host disease biology and therapy
Bruce R. Blazar et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Graft versus Leukemia Reactivity after Allogeneic Stem Cell Transplantation
J. H. Frederik Falkenburg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients
Mei Guo et al.
BLOOD (2011)
Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution
Ning Li et al.
BLOOD (2011)
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
Pleun Hombrink et al.
PLOS ONE (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Edus H. Warren et al.
BLOOD (2010)
Concomitant Tumor and Minor Histocompatibility Antigen-Specific Immunity Initiate Rejection and Maintain Remission from Established Spontaneous Solid Tumors
Rodrigo Hess Michelini et al.
CANCER RESEARCH (2010)
Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited
Abhinav Deol et al.
CANCER TREATMENT REVIEWS (2010)
Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients
T. Mutis et al.
LEUKEMIA (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up
Tanzina Haque et al.
TRANSPLANTATION (2010)
Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer
Robert R. Jenq et al.
NATURE REVIEWS CANCER (2010)
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units
Michael R. Verneris et al.
BLOOD (2009)
Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen
Jason A. Dubovsky et al.
CLINICAL CANCER RESEARCH (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease
Steven A. McCarroll et al.
NATURE GENETICS (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease
Robbert Spaapen et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-γ receptor-deficient hosts
Jean-Sebastien Delisle et al.
BLOOD (2008)
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations
Eric Spierings et al.
PLOS GENETICS (2007)
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
Cornelis A. M. van Bergen et al.
BLOOD (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation
Ann Mullally et al.
BLOOD (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of T-cell epitopes for cancer immunotherapy
J. H. Kessler et al.
LEUKEMIA (2007)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation
Alison W. Loren et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
EH Slager et al.
BLOOD (2006)
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
BC Rijke et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses
P Reddy et al.
NATURE MEDICINE (2005)
T cells targeted against a single minor histocompatibility antigen can cure solid tumors
MC Meunier et al.
NATURE MEDICINE (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors
K Noonan et al.
CANCER RESEARCH (2005)
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
SSB Randolph et al.
BLOOD (2004)
Molecules and mechanisms of the graft-versus-leukaemia effect
M Bleakley et al.
NATURE REVIEWS CANCER (2004)
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
K Rezvani et al.
BLOOD (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The immunogenomics of minor histocompatibility antigens
D Roopenian et al.
IMMUNOLOGICAL REVIEWS (2002)
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
P Fontaine et al.
NATURE MEDICINE (2001)
分享论文
